Oral Chinese patent medicines for acute myocardial infarction after percutaneous coronary intervention: A protocol for systematic review and network meta-analysis

Acute myocardial infarction (AMI) is a serious and fatal heart disease with one of the highest mortality rates in the world. In some countries, percutaneous coronary intervention (PCI) is the preferred reperfusion strategy after AMI, but it cannot achieve safe and effective treatment of AMI after PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wei, Xiong, Fan-Jie, Feng, Shu-Gui, Li, Yan-Ming, Lei, Xing-Hua, Jia, Shi-Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726348/
https://www.ncbi.nlm.nih.gov/pubmed/36482597
http://dx.doi.org/10.1097/MD.0000000000031927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726348/
https://www.ncbi.nlm.nih.gov/pubmed/36482597
http://dx.doi.org/10.1097/MD.0000000000031927

Ejemplares similares